Chemicals in kids new WHO foe

Ministers call for 'decisive action,' while the chemical industry says WHO threatens business

Written byRobert Walgate
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

BUDAPEST—At a meeting of European health ministers here last week, the World Health Organization (WHO) moved action against synthetic chemicals that affect child development higher on the global health agenda.

Scientists said action was overdue, with tens of thousands of novel chemicals of unknown effect circulating in our bodies, but chemical industry representatives told The Scientist the new stance could delay chemical research and development by 15 years, and raise issues of international competition and equity.

Philip Landrigan of Mount Sinai School of Medicine, NY, said in a scientific meeting at the Budapest summit that "children are very heavily exposed to an enormous number of synthetic chemicals that have been invented in the last 30 to 50 years, that didn't even exist before, that are widespread in the environment, and present in children's bodies and mother's milk."

While the toxic effects of a few, like lead and methyl mercury, are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies